Dec 30, 2024

Checkpoint Therapeutics Q4 2024 Earnings Report

Expected Revenue:$0
-100.0% YoY
Expected EPS:-$0.22
+59.3% YoY

Checkpoint Therapeutics

Checkpoint Therapeutics